Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 41

Sort by

Sort Order Select

Journal Articles

Statins Potentiate Aminopeptidase Inhibitor (pro)Drug Activity in Acute Myeloid Leukemia Cells

Jacqueline Cloos, PhD, Godefridus J Peters, PhD, Marjon Al, BSc, Yehuda G Assaraf, PhD, Lixia Wang, PhD, Jack W. Singer, MD, Jorge E. Cortes, MD, Gert J. Ossenkoppele, MD PhD, Gerrit Jansen, PhD

Blood (2018) 132 (Supplement 1): 3945.

https://doi.org/10.1182/blood-2018-99-114447

Published: 2018

Journal Articles

Use of Statins, Survival and Incidence of Thrombosis Among Older Adults with Essential Thrombocythemia: A Population-Based Study

Nikolai Podoltsev, MD PhD, Mengxin Zhu, MPH, Rong Wang, PhD, Amer M. Zeidan, MBBS, MHS, Xiaoyi Wang, MD MPH, Scott F Huntington, MD MPH, Smith Giri, MBBS, Amy J. Davidoff, PhD MS, Steven D. Gore, MD, Xiaomei Ma, PhD

Blood (2018) 132 (Supplement 1): 4865.

https://doi.org/10.1182/blood-2018-99-119118

Published: 2018

Journal Articles

Structure-Function Relationships of Novel Benzimidazole-Based Inhibitors of the Isoprenoid Biosynthetic Pathway in Myeloma Cells

Michelle L. Varney, MS, Nazmul H. Bhuiyan, B.S., David F. Wiemer, PhD, Sarah A. Holstein, MD PhD

Blood (2017) 130 (Supplement 1): 3345.

https://doi.org/10.1182/blood.V130.Suppl_1.3345.3345

Published: 2017

Journal Articles

Upregulation of Alternatively Glycosylated Smoothened (SMO) Is Involved in Doxorubicin (DXR) Resistance in Diffuse Large B-Cell Lymphoma

Nitin Agarwal, PhD, Kranthi Kunkalla, MS, Sandra Sanchez, MD, Amineh Vaghefi, MD, Darius Juskevicius, PhD, Alexandar Tzankov, Ramiro E Verdun, PhD, Ralf Landgraf, PhD, Francisco Vega, MD PhD

Blood (2017) 130 (Supplement 1): 3839.

https://doi.org/10.1182/blood.V130.Suppl_1.3839.3839

Published: 2017

Journal Articles

Effects of Isoprenoid Biosynthetic Pathway Inhibition on Glucose Uptake in Myeloma Cells

Kaitlyn M. Dykstra, PhD, Sarah A. Holstein, MD PhD

Blood (2016) 128 (22): 3300.

https://doi.org/10.1182/blood.V128.22.3300.3300

Published: 2016

Journal Articles

Synergistic Inhibition of Geranylgeranyl Diphosphate Synthase By a Mixture of Olefin Stereoisomers

Cheryl Allen, BS, Joseph I. Metzger, BA, Veronica S. Wills, PhD, Huaxiang Tong, PhD, Sandhya Kortagere, PhD, David F. Wiemer, PhD, Sarah A. Holstein, MD PhD

Blood (2016) 128 (22): 2320.

https://doi.org/10.1182/blood.V128.22.2320.2320

Published: 2016

Journal Articles

Effects of Novel Tropolones with Selective HDAC Inhibitor Activity in Myeloma Cells

Alyssa M. Aldridge, Kaitlyn M. Dykstra, PhD, Cheryl Allen, BS, Sean H. Colligan, BS, Eric R. Falcone, MS, Andrew J. Wiemer, PhD, Dennis L. Wright, PhD, Sarah A Holstein, MD PhD

Blood (2015) 126 (23): 3247.

https://doi.org/10.1182/blood.V126.23.3247.3247

Published: 2015

Journal Articles

Long Term Statin Use and Risk of Multiple Myeloma Among 15.5 Million Taiwanese Adults: A Retrospective Cohort Study

Brian C.-H. Chiu, PhD, Jin-Hua Chen, PhD, Yu-Chun Yen, MS, Gregory S. Calip, PharmD, MPH, PhD, Chun-Ru Chien, MD PhD, Habibul Ahsan, MD MMedSc, Ya-Chen T Shih, PhD, Kuang-Fu Cheng, PhD

Blood (2015) 126 (23): 4198.

https://doi.org/10.1182/blood.V126.23.4198.4198

Published: 2015

Journal Articles

A Novel Class of Geranylgeranyl Diphosphate Synthase Inhibitors: Structure-Activity Relationships of Homoisoprenoid Triazoles in Myeloma Cells

Veronica S. Wills, B.S., Cheryl Allen, BS, Ella J. Born, B.A., Xiang Zhou, B.S., David F. Wiemer, PhD, Sarah A Holstein, MD PhD

Blood (2014) 124 (21): 2156.

https://doi.org/10.1182/blood.V124.21.2156.2156

Published: 2014

Journal Articles

Lovastatin Induces Platelet Apoptosis

Qing Zhao, PhD, Mengxing Chen, Ling Zhou, Lili Zhao, Rong Yan, PhD, Kesheng Dai, PhD

Blood (2014) 124 (21): 5030.

https://doi.org/10.1182/blood.V124.21.5030.5030

Published: 2014

Journal Articles

Prospective Analysis Of Statin Use and Risk Of Non-Hodgkin’s Lymphoma In The Women’s Health Initiative Cohort

Pinkal Desai, Robert Wallace, Matthew Anderson, Abdel Alqwasmi, Barbara V. Howard, Chunyuan Wu, Monica Safford, Lisa W. Martin, Nicolas Schlecht, Simin Liu, Jeremy Cetnar, Dominic Cirillo, Allison Jay, JoAnn E. Manson, Michael S. Simon

Blood (2013) 122 (21): 4279.

https://doi.org/10.1182/blood.V122.21.4279.4279

Published: 2013

Journal Articles

Targeting Rab Geranylgeranylation Disrupts Myeloma-Stromal Cell Interactions

Moaaz Soliman, Ella J. Born, BA, Sara V. Hartman, BS, Sarah A. Holstein, MD, PhD

Blood (2012) 120 (21): 1354.

https://doi.org/10.1182/blood.V120.21.1354.1354

Published: 2012

Journal Articles

Evaluation of Autophagy Modulators and Isoprenoid Biosynthetic Pathway Inhibitors in Multiple Myeloma Cells

Ella J. Born, BA, Sara V. Hollins, BS, Sarah A. Holstein, MD, PhD

Blood (2011) 118 (21): 2488.

https://doi.org/10.1182/blood.V118.21.2488.2488

Published: 2011

Journal Articles

Statins Increase Antileukemic Potency of Imatinib Through the Inhibition of MDR/ABCB1 and BCRP/ABCG2 Drug Transporters Activity

Eliza Glodkowska-Mrowka, MD, Piotr Mrowka, M.Sc., Magdalena Winiarska, PhD, Grzegorz Basak, MD, PhD, Joanna Niesiobedzka-Krezel, MD, Ilona Seferynska, MD, PhD, Pawel Krzysztof Wlodarski, MD, PhD, Marek Jakobisiak, MD, PhD, Tomasz Stoklosa, MD, PhD

Blood (2011) 118 (21): 2742.

https://doi.org/10.1182/blood.V118.21.2742.2742

Published: 2011

Journal Articles

KLF2 and KLF4 Are Essential Mediators of the Anti-Thrombotic Effects of Statins in the Presence of Antiphospholipid/Anti-ß 2 GPI Antibodies,

Kristi L Allen, Ph.D., Mukesh K Jain, MD, Keith R. McCrae, MD

Blood (2011) 118 (21): 3272.

https://doi.org/10.1182/blood.V118.21.3272.3272

Published: 2011

Journal Articles

A Mechanistic Rationale for the Use of Statins to Enhance JAK Inhibitor Therapy in MPNs

Lori N. Griner, Kathy L. McGraw, Joseph O. Johnson, Alan F. List, MD, Gary W. Reuther

Blood (2011) 118 (21): 2816.

https://doi.org/10.1182/blood.V118.21.2816.2816

Published: 2011

Journal Articles

Potentiation of the Antileukemic Effects of Imatinib through the Modulation of BCRP/ABCG2 Activity.

Eliza Glodkowska-Mrowka, MD, Magda Winiarska, PhD, Piotr Mrowka, M.Sc., Grzegorz Basak, MD, PhD, Joanna Niesiobedzka-Krezel, MD, Ilona Seferynska, MD, PhD, Tomasz Stoklosa, MD, PhD

Blood (2010) 116 (21): 3400.

https://doi.org/10.1182/blood.V116.21.3400.3400

Published: 2010

Journal Articles

The Lamin B Receptor Provides Sterol Reductase Activities Critical to Neutrophil Development: Implications for Cholesterol Biosynthesis In Regulating Myelopoiesis

Gayathri Subramanian, MS, Pulkit Chaudhury, MS, Peter Gaines, PhD

Blood (2010) 116 (21): 389.

https://doi.org/10.1182/blood.V116.21.389.389

Published: 2010

Journal Articles

Interaction Between Heat Shock Protein Inhibitors and Isoprenoid Biosynthetic Pathway Inhibitors In Multiple Myeloma Cells

Ella J. Born, BA, Sara V. Hollins, Sarah A. Holstein, MD, PhD

Blood (2010) 116 (21): 2895.

https://doi.org/10.1182/blood.V116.21.2895.2895

Published: 2010

Journal Articles

Exploiting the mevalonate pathway to distinguish statin-sensitive multiple myeloma

James W. Clendening, Aleksandra Pandyra, Zhihua Li, Paul C. Boutros, Anna Martirosyan, Richard Lehner, Igor Jurisica, Suzanne Trudel, Linda Z. Penn

Blood (2010) 115 (23): 4787–4797.

https://doi.org/10.1182/blood-2009-07-230508

Published: 2010

Includes: Supplemental data

NARROW

Statins Potentiate Aminopeptidase Inhibitor (pro)Drug Activity in Acute Myeloid Leukemia Cells

Use of Statins, Survival and Incidence of Thrombosis Among Older Adults with Essential Thrombocythemia: A Population-Based Study

Structure-Function Relationships of Novel Benzimidazole-Based Inhibitors of the Isoprenoid Biosynthetic Pathway in Myeloma Cells

Upregulation of Alternatively Glycosylated Smoothened (SMO) Is Involved in Doxorubicin (DXR) Resistance in Diffuse Large B-Cell Lymphoma

Effects of Isoprenoid Biosynthetic Pathway Inhibition on Glucose Uptake in Myeloma Cells

Synergistic Inhibition of Geranylgeranyl Diphosphate Synthase By a Mixture of Olefin Stereoisomers

Effects of Novel Tropolones with Selective HDAC Inhibitor Activity in Myeloma Cells

Long Term Statin Use and Risk of Multiple Myeloma Among 15.5 Million Taiwanese Adults: A Retrospective Cohort Study

A Novel Class of Geranylgeranyl Diphosphate Synthase Inhibitors: Structure-Activity Relationships of Homoisoprenoid Triazoles in Myeloma Cells

Lovastatin Induces Platelet Apoptosis

Prospective Analysis Of Statin Use and Risk Of Non-Hodgkin’s Lymphoma In The Women’s Health Initiative Cohort

Targeting Rab Geranylgeranylation Disrupts Myeloma-Stromal Cell Interactions

Evaluation of Autophagy Modulators and Isoprenoid Biosynthetic Pathway Inhibitors in Multiple Myeloma Cells

Statins Increase Antileukemic Potency of Imatinib Through the Inhibition of MDR/ABCB1 and BCRP/ABCG2 Drug Transporters Activity

KLF2 and KLF4 Are Essential Mediators of the Anti-Thrombotic Effects of Statins in the Presence of Antiphospholipid/Anti-ß 2 GPI Antibodies,

A Mechanistic Rationale for the Use of Statins to Enhance JAK Inhibitor Therapy in MPNs

Potentiation of the Antileukemic Effects of Imatinib through the Modulation of BCRP/ABCG2 Activity.

The Lamin B Receptor Provides Sterol Reductase Activities Critical to Neutrophil Development: Implications for Cholesterol Biosynthesis In Regulating Myelopoiesis

Interaction Between Heat Shock Protein Inhibitors and Isoprenoid Biosynthetic Pathway Inhibitors In Multiple Myeloma Cells

Exploiting the mevalonate pathway to distinguish statin-sensitive multiple myeloma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only